Introduction
This analysis examines the historical and forecast performance for Merck KGaA in the prescription pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
Merck KGaA: PharmaVitae Profile
Reasons to Purchase
- Benchmark Merck KGaA’s performance against key rivals in the prescription pharmaceutical sector
- Learn how the continued strong performance of Erbitux will drive the company’s prescription pharma business in the period to 2015
- Evaluate the company’s more focused business strategy and see how its extensive restructuring has affected its operating cost and profit margins
